The Annals of Dermatological Research (ADR) is dedicated to advancing dermatological science through the publication of high-quality, peer-reviewed research. Our Aims and Scope reflect a broad and inclusive vision that covers both fundamental and clinical aspects of dermatology, ensuring relevance for scientists, clinicians, industry professionals, and policymakers alike.

Overall Aim

ADR aims to serve as a comprehensive, open-access resource that facilitates scholarly communication in the field of dermatology. The journal emphasizes innovation, integrity, and impact in dermatological research, with a mission to:

Advance understanding of skin biology, diseases, and therapies.
Bridge clinical practice and laboratory research.
Promote interdisciplinary collaboration across dermatology and related sciences.
Encourage evidence-based clinical practice through high-quality studies.
Facilitate global knowledge sharing with open access dissemination.

Scope of the Journal

ADR welcomes original research articles, reviews, short communications, case reports, editorials, and commentaries across all areas of dermatology. The journal particularly values contributions that demonstrate innovation, clinical applicability, or interdisciplinary significance.

Core Focus Areas

Clinical Dermatology: Advances in diagnosis, treatment, and patient care across common and rare skin conditions.
Dermatopathology: Microscopic and molecular analysis of skin disorders, including diagnostic and prognostic markers.
Cosmetic and Aesthetic Dermatology: Research on procedures, products, and technologies for aesthetic enhancement and skin rejuvenation.
Dermato-Oncology: Prevention, diagnosis, and treatment of skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma.
Immunodermatology: Mechanisms of autoimmune skin diseases and immune-mediated disorders such as psoriasis, pemphigus, and lupus.
Pediatric Dermatology: Dermatological conditions affecting children and neonates, with focus on unique diagnostic and therapeutic challenges.
Infectious Dermatology: Viral, bacterial, fungal, and parasitic infections of the skin and their clinical implications.
Photodermatology: Research on ultraviolet radiation, phototherapy, and related effects on skin health.
Cutaneous Pharmacology & Therapeutics: Drug development, clinical trials, and novel therapies for skin diseases.
Translational Research: Bridging laboratory research and clinical application in dermatology.

Multidisciplinary Integration

ADR recognizes that dermatology intersects with multiple scientific domains, including immunology, oncology, endocrinology, molecular biology, and genetics. Our scope therefore encourages cross-disciplinary submissions that integrate dermatology with broader biomedical fields.

Article Types Considered

Original Research Articles: Comprehensive reports of novel studies in dermatology.
Review Articles: In-depth, critical assessments of emerging topics and established research areas.
Case Reports & Case Series: Rare and instructive clinical presentations of dermatological interest.
Editorials & Commentaries: Expert perspectives on pressing dermatological issues.
Letters to the Editor: Short, focused communications and responses to published work.
Clinical Guidelines: Consensus-based recommendations for dermatological practice.

Geographic & Demographic Inclusivity

ADR maintains a global outlook by inviting contributions from authors worldwide, ensuring representation from diverse regions, ethnicities, and populations. Research involving underrepresented communities, rare diseases, or region-specific dermatological challenges is especially welcome.

Relevance to Practice and Policy

The journal not only focuses on advancing scientific knowledge but also prioritizes its translation into clinical practice and health policy. By promoting articles that influence treatment guidelines, patient safety, and public health initiatives, ADR supports evidence-based decision-making in dermatology.

Commitment to Innovation

ADR encourages submissions exploring emerging technologies such as artificial intelligence, machine learning, teledermatology, and digital health tools in dermatological research and clinical care. These innovations are transforming diagnosis, patient engagement, and therapeutic outcomes.

FAQs on Scope

Is ADR limited to clinical studies?

No. ADR embraces both clinical and laboratory-based studies, provided they contribute meaningfully to dermatological science.

Do you publish negative results?

Yes. ADR values well-designed studies regardless of outcome, supporting transparency and reducing publication bias.

What about interdisciplinary submissions?

Submissions that integrate dermatology with other fields (e.g., oncology, genetics, bioinformatics) are encouraged.

Conclusion

In summary, ADR’s Aims and Scope reflect its commitment to being a dynamic, inclusive, and forward-looking journal. By embracing both established and emerging areas of dermatological science, ADR contributes to the improvement of global skin health and the professional growth of its contributors.